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Autismisaneurodevelopmentaldisordercharacterizedbydeﬁcits
inreciprocalsocialinteractionandcommunication,andrepetitive
and stereotyped behaviors and interests. Previous genetic studies
ofautismhaveshownevidenceoflinkagetochromosomes2q,3q,
7q,11p,16p,and17q.However,thecomplexityandheterogeneity
ofthedisorderhavelimitedthesuccessofcandidategenestudies.
It is estimated that 5% of the autistic population carry structural
chromosome abnormalities. This article describes the molecular
cytogenetic characterization of two chromosome 2q deletions in
unrelated individuals, one of whom lies in the autistic spectrum.
Both patients are affected by developmental disorders with lan-
guage delay and communication difﬁculties. Previous karyotype
analysesdescribedthedeletionsas[46,XX,del(2)(q24.1q24.2)dn].
Breakpoint reﬁnement by FISH mapping revealed the two dele-
tionstooverlapbyapproximately1.1Mbofchromosome2q24.1,a
region which contains just one gene—potassium inwardly recti-
fying channel, subfamily J, member 3 (KCNJ3). However, a
mutation screen of this gene in 47 autistic probands indicated
that coding variants in this gene are unlikely to underlie the
linkage between autism and chromosome 2q. Nevertheless, it
remainspossiblethat variantsinthe ﬂankinggenes may underlie
evidence of linkage at this locus.   2009 Wiley-Liss, Inc.
Key words: autistic disorder; developmental language disorders;
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INTRODUCTION
Autism (OMIM 209850) is a neurodevelopmental disorder char-
acterized by a triad of deﬁcits in reciprocal social interaction and
communication, and repetitive and stereotyped behaviors and
interests [World Health Organisation, 1993; American Psychiatric
Association, 1994].
A large-scale UK-based population survey estimated the preva-
lence of autistic spectrum disorders (ASDs) to be between 0.90%
and1.42%[Bairdetal.,2006].Whilecontemporarystudiessuchas
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  2009 Wiley-Liss, Inc. 588this consistently report a higher incidence than that of traditional
investigations, it remains a matter of debate whether this increase
representsagenuinetrajectoryoranimprovementindetectionand
diagnosis.
Family and twin studies reliably indicate the presence of strong
genetic factors in the susceptibility to autistic disorder and herita-
bility estimates are generally above 90%. Monozygotic twin con-
cordanceratesaresigniﬁcantlyhigherthanthosefordizygotictwins
and siblings of affected individuals are 20–30 times more likely to
developanASDthanamemberofthegeneralpopulation[reviewed
by Sykes and Lamb, 2007]. However, it is becoming increasingly
clearthat,inthemajorityofcases,thegeneticsunderlyingASDsare
likely to be highly complex involving numerous genetic variants at
both the sequence and structural level as well as environmental
factors [Pickles et al., 1995; Pritchard, 2001; The Autism Genome
Project Consortium, 2007].
Overthelastdecade,severallinkagestudieshavebeencompleted
for autism and related disorders [reviewed by Klauck, 2006]. The
results of these, alongside other molecular investigations, have
meant that almost every chromosome has historically been impli-
cated in the onset of ASDs. However, the abundance of genetic
studies has allowed the derivation of a core set of chromosomal
regions which appear to be of importance across the broad autistic
spectrum. These principal loci are found on chromosomes 2q
[Philippe et al., 1999; IMGSAC 2001; Buxbaum et al., 2001; Shao
et al., 2002; Morrow et al., 2008], 3q [Auranen et al., 2002; Shao
et al., 2002], 7q [CLSA, 1999; IMGSAC, 2001; Liu et al., 2001;
Auranen et al., 2002], 11p [The Autism Genome Project Consor-
tium,2007],16p[Philippeetal.,1999;IMGSAC,2001;Lambetal.,
2005],and17q[IMGSAC,2001;Yonanetal.,2003;McCauleyetal.,
2005;Alarconetal.,2005].Numerousassociationstudieshavebeen
performed within these regions. However, while rare mutations
have been reported in some candidate genes, these are often found
toaffectrelativelyfewautisticindividualsandareseldomsupported
by association trends within larger cohorts. The lack of deﬁnitive
linkageandassociation-basedresultsintheautismﬁeldarethought
to reﬂect the phenotypic heterogeneity of the disorder and the
complexity of the underlying genetic architecture.
An alternative approach, which has proved helpful for other
disorders, is the characterization of cytogenetic abnormalities
which segregate with disease phenotype. Structural cytogenetic
abnormalities are present at a higher rate in autistic cohorts than
one would expect to ﬁnd in the general population [reviewed by
Abrahams and Geschwind, 2008]. However, with the exception of
maternally derived duplications of a region on chromosome 15q,
these abnormalities do not form obvious clusters. In a review of
cytogenetic abnormalities inautism,Vorstman etal.,[2006]desig-
nated chromosomes 2q37, 5p, 7, 11q, 15q, 16q, 17p, 18q, 22q, and
Xp as ‘‘cytogenetic regions of interest’’ deﬁned by a minimum of
fourcasereportsatthesamelocus.Recentmethodologicaladvances
have enabled the screening of the entire genome for both large-
scale (cytogenetic) and sub-microscopic (copy number
variants—CNVs) deletions and duplications in large autistic
populations [Sebat et al., 2007; The Autism Genome Project
Consortium, 2007; Marshall et al., 2008; Christian et al., 2008]. In
line with the karyotypic ﬁndings, each of these studies reported an
increased de novo CNV rate in affected individuals ( 7%) above
that reported in controls ( 1%). These collaborative efforts have
enabled the identiﬁcation of the ﬁrst nonsyndromic ASD suscepti-
bilitygenesincludingSHANK3onchromosome22q[Durandetal.,
2007; Moessner et al., 2007], NRXN1 on chromosome 2p [Kim
etal.,2008],NLGN3andNLGN4onchromosomeX[Jamainetal.,
2003;Laumonnieretal.,2004;Yanetal.,2005;Lawson-Yuen etal.,
2008] and a microdeletion on chromosome 16p11 [Kumar et al.,
2008;Weissetal.,2008].However,itisclearthatmutationsinthese
genes account for only a small proportion of autistic cases, further
supporting the hypothesis that the genetic basis of autism may
resemble that of mental retardation, in which the clinical disorder
assimilates a variety of distinct rare syndromes that present with
similar surface characteristics.
Thisarticledescribesthemolecularcytogeneticcharacterization
of two chromosome 2q deletions in unrelated individuals with
developmental delays and language impairment. The difﬁculties
characterized in one of these patients were found to fall within the
autistic spectrum (Pervasive Developmental Disorder (PDD)).
Routinekaryotypeanalysesdescribedthedeletionsinthesepatients
asdel(2)(q24.1q24.2)denovo.Thisregionisrelativelydistanttothe
subtelomeric band commonly deleted in autistic patients
[2q37—Lukusa et al., 2004; Falk and Casas, 2007], but lies in a
region which has repeatedly shown linkage to autism
[AUTS5—Philippe et al., 1999; IMGSAC, 2001; Buxbaum et al.,
2001;Shaoetal.,2002]andhasalsobeenimplicatedtoplayarolein
language impairment [Bartlett et al., 2004] and IQ development
[INTLQ3—Posthuma et al., 2005] (Fig. 1) both of which are
relevant to the patients described here. By means of ﬂuorescence
in situ hybridization (FISH) mapping with bacterial artiﬁcial
chromosomes (BAC) clone probes along the critical chromosomal
bands wedeﬁne the boundaries of both deletions and the region of
overlap.Thecommondeletedsegmentcontainsasinglegenewhich
encodes a potassium channel expressed in the cardiovascular and
nervous systems. We go on to sequence the coding regions of this
gene in 47 unrelated autistic probands.
It is hoped that cumulative evidence across studies such as this
will aid the search for autism susceptibility genes by allowing the
reﬁnementofthelargechromosomalregionstypicallyidentiﬁedby
linkage studies.
MATERIALS AND METHODS
Clinical Reports
Patient 1. This British 12-year-old girl was originally referred
because of a mild developmental delay particularly affecting her
speech and language. She also had recurrent infections, failure to
thrive and short stature.
She is the middle of three children born at term weighing 2.9 kg.
Both her siblings were well and there was no contributory family
history. Thepregnancy waslargely uneventfulbutshewasnotedto
besmallfordates.Hergrowthremainedslowintheneonatalperiod
although there were no particular feeding difﬁculties. She had an
operation for bilateral inguinal hernia at 8 weeks and was exten-
sively investigated for her failure to thrive (celiac screen, thyroid
function tests and a cystic ﬁbrosis screen were all normal). She was
prone to recurrent respiratory tract infections and was found to
have a mildly low IGA level. At 18 months she was noted to have a
NEWBURY ET AL. 589softejectionsystolicmurmurwhichwasinvestigatedandprovedto
be a functional murmur with a structurally normal heart. Subse-
quently,attheageof13years,PatentDuctusArteriosus(PDA)was
diagnosed and surgically corrected. She was also noted to have an
apparent convergent squint which remains underreview. A formal
assessment showed her to have no manifest squint with normal
refraction andopticdiscs.Atage10yearsshehadapoplidealbursa
cyst surgically removed from her leg.
At8months,hermotherwasconcernedabout herhearingasshe
wasnotbabbling.Thetympanogramswereﬂat.Shewasduetohave
grommetsinsertedwhenthesituationimprovedandsheeventually
passed a hearing test.
Hermotormilestoneswerenormal:shesatat6months,walkedat
14monthsandhadsomebabbleattheageofayear.Shewasnotedto
haveveryfewsinglewordsby18monthsandconcernsregardingher
poor speech and slow language acquisition remained.
On examination, she was a petite child with growth parameters
between the 2nd and 9th centiles. She was not overtly dysmorphic
buthadafewdistinctivefeatureswithslightlydeepseteyes,narrow
palpebralﬁssures,asmallmouthandsomewhatprominentlow-set
ears (Fig. 2).
Assessment aged 6 years, at a time of continuing concern about
communicative competence, with WISC 3 and CELF3 showed
particular problems with all language based tasks, receptive score
70,expressive59butherperformanceandverbalIQwere80and73
respectively (all tests mean 100 SD 15). The clinical ﬁnding was of
‘‘mainly expressive language difﬁculties but other problems that
will affect all aspects of increasingly abstract reasoning and
thinking.’’ She also showed over-anxiety, social anxiety, sensory
sensitivities and some rigidity of behaviors.
Later assessment(at age 12 years) using the WISC showed global
learning difﬁculties (FSIQ64), CELF language assessment was in
line with the IQ both receptively and expressively. Socially she was
immature,inlinewithIQandhadnoautismorASDclinicallyoron
ADOS.
Patient2. ThisBritishgirl,ofChineseparentage,wasreferredat
the age of 61= 2 years with a diagnosis of pervasive developmental
disorder and attention deﬁcit difﬁculties.
Shewasthesecondchildofunrelatedparents.Anoldersisterand
younger brother had no learning or behavioral problems. The
mother had a nephew who had delayed speech until the age of 4
years but his subsequent development had been normal.
She was born at term following an uneventful pregnancy and
delivery. There were no neonatal problems. The parents were ﬁrst
concernedabout her developmentatthe ageof 18months.Shedid
not walk independently until 18 months but her language devel-
opment and communication were signiﬁcantly more delayed. She
startedtousewordsjustbeforetheageof3yearsandwasassessedto
haveacomplexdevelopmentallearningproblemwithconsiderable
attentiondeﬁcitwhichrequiredtreatment.Shehadsomeobsessive
traits and had always been a poor sleeper. In retrospect, there were
concerns from the age of 6 months onwards as she showed less eye
contactandwaspooratplaycomparedtohersiblings.Herparents
also felt that she had shown slower acquisition of social maturity,
senseofdangerandthatherbehaviorwassometimesinappropriate
compared to her peers.
Onexaminationshewasapleasantandfriendlygirlwhoattimes
could be socially disinhibited. There was no dysmorphism and
growthparameterswereonthe25thcentile.Detailedpsychometric
assessment showed signiﬁcant global difﬁculties in cognition,
FIG. 1. Position of chromosome 2q linkages. Position of current
chromosome 2q deletions are shown by the bars on the left.
Position of relevant linkage studies are shown on the right. (1)
Deletion mapped in patient 1. (2) Deletion mapped in Patient 2.
(3) Boundaries of deleted region in Patients 1 and 2. (4) Linkage
to autism [Philippe et al., 1999] AUTS5. (5) Linkage to autism
[Buxbaum et al., 2001] AUTS5. (6) Linkage to autism [IMGSAC,
2001]AUTS5.(7)Linkagetolanguageimpairment[Bartlettetal.,
2004]. (8) Linkage to IQ [Posthuma et al., 2005] INTLQ3.
FIG. 2. Patient1.[Colorﬁgurecanbeviewedintheonlineissue,which
is available at www.interscience.wiley.com.]
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the areas of understanding and manipulating visually presented
material.
When last reviewed at the age of 12 years she had shown
considerable progress with her speech and was using some sign
language. She was diagnosed to have bi-polar disorder with some
psychoticfeaturesfor whichshewasreceivingappropriate support
and treatment.
Both patients were assessed by a single clinician who noted the
existence of shared developmental delays and severe expressive
communication deﬁcits between individuals.
Fluorescence in situ hybridization (FISH). Lymphoblastoid
cell lines were established at the European Collection of Cell
Cultures(ECACC)foreachpatientandusedtoproducemetaphase
chromosome spreads ﬁxed on slides. The cells were cultured in
RPMI-1640 supplemented with 10% fetal bovine serum (FBS) and
1% L-Glutamine (Sigma, www.sigmaaldrich.com) at 37 Ci na5 %
CO2 incubator. One hour before harvesting the cells were treated
with Colcemid (Invitrogen, www.invitrogen.com) at a ﬁnal con-
centrationof0.2mg/ml.Theywerethenresuspendedinprewarmed
(to37 C)hypotonicsolution(0.0075MKCl)for5minandﬁxedin
three changes of 3:1 methanol: acetic acid. Slides were prepared
following standard procedures and aged at  20 C.
BAC cultures were grown overnight and DNA extracted from
individual clones by a standard miniprep procedure. DNA was
labelledbynicktranslation(Vysiskit)usingeitherBiotin-16-dUTP
or Digoxigenin-11-dUTP (Roche, www.roche-applied-
science.com). This labelled BAC DNA was ethanol precipitated in
a mix of Salmon testis DNA (Gibco BRL), Escherichia coli tRNA
(Roche,www.roche-applied-science.com)and3Msodiumacetate.
They were then dried on a heating block with a 50  excess of
Human Cot-1 DNA (Gibco) to block repetitive sequences and
resuspended in hybridization solution (50% formamide, 10%
dextran sulfate, 2  SSC). Denatured probes were pipetted onto
thepreparedslidesandincubatedovernighttoallowhybridization.
Theslidesweredenaturedin70%formamide,quenchedin2 SSC
and then dehydrated in an ethanol series. Following hybridization,
the slides were washed in 50% formamide and 2  SSC. The
Biotinylated probes were detected with Texas Red-conjugated
Streptavidin (Invitrogen, www.invitrogen.com), followed by a
layer of Biotinylated anti-streptavidin (Vector Laboratories,
www.vectorlabs.com) and a ﬁnal layer of Texas Red-conjugated
Streptavidin. The Digoxigenin probes were detected using Mouse
anti-Digoxigenin antibody (Roche) and Goat anti-Mouse Alexa-
488(MolecularProbes).TheslidesweremountedwithVectashield
(Vector Laboratories) containing 40,6-diamidino-2-phenylindole
(DAPI) for chromosome counterstaining. The slides were exam-
inedusinganOlympusBX-51epiﬂuorescencemicroscopecoupled
to a Sensys charge-coupled device (CCD) camera (Photometrics,
www.photomet.com). Aminimumof100nucleiwereanalyzedfor
each hybridization experiment. Texas Red, Alexa-488 and DAPI
ﬂuorescence images were taken as separate grey-scale images using
speciﬁc ﬁlter combinations and then pseudocoloured and merged
using the software package Genus (Applied Imaging International,
www.genetix.com).
ABACtilingpathwasidentiﬁedfromtheUCSCgenomebrowser
(http://genome.ucsc.edu/) for the region predicted to contain the
deletions. All clones were chosen from the RPCI-11 library
[Osoegawa et al., 2001] and obtained from the BACPAC resource
center (BPRC) [http://bacpac.chori.org/] as bacterial LB agar stab
cultures.TheBACprobesusedforinsituhybridizationarelistedin
Table I. As the deletion intervals were narrowed, clone pairs were
selected independently for each patient and therefore, not every
clone was hybridized to both patients.
Mutationscreen. ThecodingregionsofKCNJ3weresequenced
in47unrelatedautisticsubjectsselectedfromtheIMGSACfamilies
that contributed to the linkage peak on chromosome 2q. This
strategy selects for cases that are more likely to carry etiological
variants at this locus compared to a random patient sample. The
ascertainmentofthesefamiliesandtheDNAcollectionprocedures
have been described in detail elsewhere [IMGSAC, 2001]. DNA
from44oftheseIMGSACpatientshavepreviouslybeencharacter-
ized on Affymetrix 10K microarrays [The Autism Genome Project
Consortium, 2007]. This investigation did not identify any CNVs
that segregated with the incidence of autism in these particular
cases.
SequencedataweredownloadedfromNCBIandusedtoidentify
intron-exon boundaries. PCR primers ﬂanking these boundaries
were designed using the Primer 3 program. For exons greater than
500 bp in size, overlapping PCR products were designed. In total,
seven fragments were required to cover the 2.9 kb of genomic
sequence. Mutations were identiﬁed by direct sequencing of each
fragment. Sequencing was performed with BigDye terminator mix
on an ABI 3730 and variants were identiﬁed using Sequence
Navigator. Primer sequences and PCR conditions are available
from authors on request.
RESULTS
In FISH experiments to metaphase chromosome spreads, 18 BAC
clones were hybridized to Patient 1, and 16 clones to Patient 2
(Table I).
In Patient 1, the proximal deletion breakpoint was found to lie
between the contiguous clones RP11-352J13 (not deleted) and
RP11-173H9(deleted)andthedistaldeletionbreakpointwasfound
to lie between the neighboring clones RP11-183M18 (deleted) and
RP11-637C13(notdeleted)(TableI).Thisdeletionspansapproxi-
mately 3.6 Mb across 2q23.3–2q24.1 and contains six genes
(FMNL2–KCNJ3—Table II).
InPatient2,bothRP11-621K10andRP11-292A10werefoundto
be partially deleted and therefore represent the boundaries of the
deletion in this individual (Table I). This deletion spans approxi-
mately 4.5 Mb across 2q24.1–2q24.2 and contains 14 genes
(KCNJ3–WDSUB1—Table II).
FISH images of the critical clones on metaphase chromosome
spreads are shown in Figure 3.
The two deletions overlap by approximately 1.1Mb of 2q24.1
(155,378,302–156,447,588) and this region contains just one
gene—potassiuminwardlyrectifyingchannel,subfamilyJ,member
3( KCNJ3) (OMIM 601534) (Table II). While the deletion bound-
aries cannot be absolutely deﬁned by FISH analysis, it appears that
thedeletioninPatient1spanstheentireKCNJ3genewhilstonlythe
30 endofthisgeneisdeletedinPatient2(BACcloneRP11-621K10).
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tional sequencesof KCNJ3 revealedseven sequencechanges within
the IMGSAC sample: Four synonymous coding changes, two
variants in the 50UTR region and one very rare variant in the
promoter region (Table III). Two of the coding variants (silent
H346 and silent S197) were previously characterized polymor-
phisms within the dbSNP database (rs17642086 and rs3111033,
respectively) and no signiﬁcant difference in allele frequencies was
identiﬁed between the autism and reported Perlegen and HapMap
CEPHsamples.Theothertwosynonymousvariantswerebothvery
rare. Table III gives full details of all changes found.
As part of a high-density SNP genotyping and association study
carried out across the chromosome 2q24–q32 region, we have
tested 42 tag SNPs, selected using data from the HapMap project
to capture common genetic variation within KCNJ3 genomic
regions. The 42 tag SNPs have been genotyped in a sample of
126 parents–child trios selected from IMGSAC multiplex families
to be linked to this region of chromosome 2 and 188 sex-matched
random European controls (ECACC). None of the SNPs provided
signiﬁcant evidence of association using either family-based or
case–controlanalysis(datanotshown,manuscriptinpreparation).
Other genes surrounding the common deletion region include
UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosa-
minyltransferase 13 (GALNT13—MIM608639), which is deleted
in Patient 1 and lies approximately 350 kb from the deletion in
Patient 2, and nuclear receptor subfamily 4, group A, member 2
(NR4A2—MIM601828) which is deleted in Patient 2 and lies
approximately 450 kb distal to the deletion in Patient 1 (Table II).
The 7 Mb spanned by the pair of deletions (chromosome
position 152,874,124–159,834,459), is covered by a single
contig (NT_005403) and contains 19 known genes (FMNL2–
WDSUB1—Table II). Of these 19 genes, all but one (GALNT5)
show some level of expression in the brain and therefore most
may be argued to represent good candidate genes for ASDs
and related neurodevelopmental disorders.
DISCUSSION
This study describes the mapping of two partially overlapping, de
novo, deletions involving chromosome 2q24 in unrelated individ-
uals affected by developmental delay, language impairment and
socialdifﬁculties. Thesedeletionsmapwithinorclosetoregionsof
chromosome 2q identiﬁed by linkage studies as candidate regions
for autism (AUTS5), language impairment and IQ (Fig. 1). Fur-
thermore, this is one of only two regions which have achieved
genomewide signiﬁcance for autistic disorder [IMGSAC, 2001].
However,theregionsidentiﬁedbylinkage studiesarelargeandthe
selection and screening of candidate genes can often prove to be a
perplexing task. Two studies have found positive association to
microsatellite markers on chromosome 2q [Romano et al., 2005;
TABLE I. BAC Clones Hybridized to Deletion Patients 1 and 2
Clone Band Start Finish Patient 1 Patient 2
RP11-185M22 2q23.3 152,371,127 152,550,162 Not deleted Not deleted
RP11-235N13 2q23.3 152,610,486 152,787,342 Not deleted
RP11-352J13* 2q23.3 152,777,784 152,967,154 Not deleted
RP11-173H9* 2q23.3 152,874,124 153,062,670 Deleted
RP11-17E6 2q23.3 153,090,115 153,243,694 Deleted Not deleted
RP11-11C17 2q23.3 153,527,697 153,682,796 Deleted Not deleted
RP11-44N6 2q24.1 154,569,776 154,710,240 Deleted Not deleted
RP11-79B5 2q24.1 155,284,349 155,457,867 Deleted Not deleted
RP11-621K10* 2q24.1 155,378,302 155,561,125 Partially deleted
RP11-109N20 2q24.1 155,561,144 155,741,920 Deleted
RP11-1089G12 2q24.1 155,671,221 155,845,226 Deleted
RP11-191I9 2q24.1 155,991,304 155,991,738 Deleted Deleted
RP11-631C11 2q24.1 155,993,432 156,156,880 Deleted
RP11-1084C19 2q24.1 156,144,997 156,334,748 Deleted
RP11-183M18* 2q24.1 156,306,492 156,447,588 Deleted
RP11-637C13* 2q24.1 156,364,263 156,545,772 Not deleted
RP11-881C12 2q24.1 156,527,066 156,717,022 Not deleted
RP11-605B16 2q24.1 156,763,265 156,938,344 Not deleted Deleted
RP11-608N6 2q24.1 157,726,618 157,912,914 Not deleted Deleted
RP11-383I5 2q24.1 157,897,634 158,065,644 Not deleted Deleted
RP11-91K6 2q24.2 159,560,745 159,715,538 Not deleted Deleted
RP11-292A10* 2q24.2 159,680,594 159,834,459 Partially deleted
RP11-357L2 2q24.2 160,186,041 160,419,283 Not deleted
RP11-615B17 2q24.2 160,419,278 160,629,949 Not deleted
Start and ﬁnish values are based on NCBI build 36, UCSC March 2006 assembly.
Underlined clones are deleted in Patient 1, italicized clones are deleted in Patient 2 and clones in bold are deleted in both cases.
Critical BACs, which deﬁne the deletion boundaries, are marked with an asterisk (*).
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performed using relatively isolated populations and the associa-
tions described map distal to the region involved in our patients
(2q31.1). A few studies have targeted candidate genes on chromo-
some2q[Bacchellietal.,2003;Rabionetetal.,2004;Hamiltonetal.,
2005;Blasietal.,2006],butonlyonehasyieldedanypositiveresults.
Bacchelli et al. [2003] screened the coding regions of nine genes
within 2q24.2–2q31.3 and performed anassociation analysis using
SNPs from this region. They identiﬁed four rare nonsynonymous
mutations within the cAMP-GEFII gene on chromosome 2q31.1
(OMIM 606058) which segregated with the autistic phenotype in
ﬁve of their 169 families. However, Bacchelli etal., caution that the
frequency of mutation could not account for the linkage signal on
chromosome 2q and the ﬁndings of this study have yet to be
replicated. No autism study to date has speciﬁcally investigated
any of the genes contained within the deletions reported here. It is
therefore hoped that the detailed characterization of chromosome
abnormalities in patients with relevant phenotypes, such as those
reported here, may aid the mapping of susceptibility genes by the
reduction of candidate linkage regions.
Theoverlapbetweenthetwodeletionsisrelativelysmall(1.1Mb)
andcontainsonlyonegene—KCNJ3.KCNJ3encodesaG-protein-
gated inward-rectiﬁer potassium channel (GIRK), which imports
potassium into a cell at a much higher rate than it exports it. There
are four known GIRK subunits and these interact in various
combinations to form functional heterodimeric channels. GIRKs
are involved in a variety of cellular processes including cell excit-
ability, heart rate, vascular tone and insulin release. In the brain,
GIRK channels control neuronal excitability and plasticity [Mark
and Herlitze, 2000]. The gene is 158 kb in length and contains 3
exons encoding a 2.9 kb transcript and a 501 amino acid protein
[Schoots et al., 1996]. The database of Genomic Variants [Iafrate
etal.,2004]reportsnoknownCNVswithinthisgene.ASNPinthe
KCNJ3 gene has been reported to be associated with idiopathic
generalized epilepsy [rs17642086 in Table III, P¼0.0097, Chioza
etal.,2002].Speciﬁcally,associationatthisSNPwasstrongestinthe
subgroup of probands with absence seizures. Although the preva-
lence of epilepsy in children with autism is signiﬁcantly increased
above that of the general population [Levisohn, 2007], neither of
thepatientsdescribedinthisarticlehaveahistoryofseizureactivity.
TABLE II. RefSeq Genes Across the Chromosome 2q23–2q24 Region
Gene RefSeq name OMIM no. Start Finish
Gene
deleted in
patient 1?
Gene
deleted in
patient 2?
ARL5A ADP-ribosylation factor-like 5A 608960 152,365,725 152,393,255 No No
CACNB4 Calcium channel, voltage-dependent, beta 4 601949 152,402,386 152,663,790 No No
STAM2 Signal transducing adaptor molecule 2 606244 152,681,560 152,740,752 No No
FMNL2 Formin-like 2 152,899,996 153,214,594 Yes No
PRPF40A Formin binding protein 3 153,216,352 153,282,221 Yes No
ARL6IP6 ADP-ribosylation-like factor 6 interacting 153,283,375 153,325,669 Yes No
RPRM Reprimo, TP53 dependant G2 arrest mediator 612171 154,042,097 154,043,568 Yes No
GALNT13 UDP-N-acetyl-D-galactosamine: polypeptide
N-acetylgalactosaminyltransferase 13
608369 154,436,671 155,018,735 Yes No
KCNJ3 Potassium inwardly rectifying channel,
subfamily J, member 3
601534 155,263,338 155,421,260 Yes Partially
NR4A2 Nuclear receptor subfamily 4, group A, member 2 601828 156,889,189 156,897,533 No Yes
GPD2 Glycerol-3-phosphate dehydrogenase 3 138430 157,000,210 157,151,161 No Yes
GALNT5 UDP-N-acetyl-alpha-D-galactosamine:polypeptide 157,822,585 157,876,159 No Yes
ERMN Ermin ERM-like protein isoform a 610072 157,883,370 157,892,392 No Yes
PSCDBP Pleckstrin homology, Sec7 and coiled-coil 604448 157,979,376 158,008,850 No Yes
ACVR1C Activin A receptor, type IC 608981 158,091,524 158,193,645 No Yes
ACVR1 Activin A type I receptor precursor 102576 158,301,204 158,440,620 No Yes
UPP2 Uridine phosphorylase 2 158,559,936 158,700,724 No Yes
CCDC148 Coiled-coil domain containing 148 158,736,723 159,021,460 No Yes
PKP4 Plakophilin 4 604276 159,021,721 159,246,186 No Yes
DAPL1 Death associated protein-like 1 159,360,086 159,380,742 No Yes
TANC1 TPR domain, ankyrin-repeat 611397 159,533,391 159,797,416 No Yes
WDSUB1 WD repeat, SAM and U-box domain containing 1 159,800,549 159,851,482 No Partially
BAZ2B Bromodomain adjacent to zinc ﬁnger domain, 2B 605683 159,883,735 160,181,305 No No
MARCH7 Axotrophin 160,277,255 160,333,330 No No
CD302 CD302 antigen 160,333,609 160,362,999 No No
LY75 Lymphocyte antigen 75 604524 160,368,113 160,469,508 No No
Start and ﬁnish values and gene positions are based on NCBI build 36, UCSC March 2006 assembly and taken from the ‘‘RefSeq Gene’’ track of UCSC. Where multiple transcripts are possible, the
maximum boundaries have been given for the transcript start and ﬁnish positions. No microRNas have been reported across this region (http://microrna.sanger.ac.uk/sequences/index.shtml).
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Chioza sample (11.7 years), it is unlikely that the deletion of this
genehascausedanepilepsy/autismtypesyndromeinthesepatients.
Sequence analysis of this gene in 47 autistic probands failed to
identify any mutations which suggest a role for KCNJ3 in ASD
susceptibility.
However,ifweconsiderthepossibilityofpositionaleffects,which
have been reported to occur up to 1 Mb away from translocation
breakpoints [Pfeifer et al., 1999], the ‘‘critical region’’ identiﬁed by
the two patients studied here may be expanded to approximately 3
Mb. This extended area contains three additional candidate
genes—UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-ace-
tylgalactosaminyltransferase13(GALNT13),nuclearreceptor sub-
family 4, group A, member 2 (NR4A2) and glycerol-3-phosphate
dehydrogenase2(GPD2)(OMIM138430)(TableII).NR4A2,which
is deleted in Patient 2 and lies approximately 450 kb distal to the
deletioninPatient 1,isessential forthedifferentiationofthenigral
dopaminergicneurons.Interestingly,thisgenehasbeenimplicated
in a range of neurological disorders including heroin addiction
[Nielsenetal.,2008],antisocialbehaviorinwomen[Prichardetal.,
2007],schizophrenia[Rojasetal.,2007]andParkinsonDisease[Xu
etal.,2002;Leetal.,2003].GALNT13,whichisdeletedinPatient1
andliesapproximately350kbproximalofthedeletioninPatient2,
showsabrainspeciﬁcexpressionpattern,whichisparticularlyhigh
in the foetal brain. It is involved in the O-linked glycosylation of
epithelialglycoproteins[Zhangetal.,2003].Twosmallvariantshave
beenreportedtoexistinintrons1and2ofthisgene[deSmithetal.,
2007; Wong et al., 2007] but no variations have been reported that
affectthecodingsequences.Glycerol-3-phosphatedehydrogenase2
(GPD2)isinvolvedinglycerolmetabolismandhasbeenimplicated
in type II diabetes [Novials et al., 1997]. All four of the genes
described above are expressed at some level in the brain and so
should therefore be considered as possible candidate genes for the
disorder in these two patients.
The Autism Chromosome Rearrangement Database [ARCD—
http://projects.tcag.ca/autism/,Marshalletal.,2008]describesonly
one autistic structural variant in the chromosome 2q24.1–2q24.2
region. This patient has a chromosome 2 to chromosome 9
translocation (46,XY,t(2;9)(q24.2;p24)) and is described as having
autism, mental retardation, speech defect, scaphocephaly/dolicho-
cephaly,behaviordisorder,hyperactivity,psychosisandupslanting
palpebral ﬁssures (MCN patient 19940001-113). In addition, in a
review article, Lauritsen et al. [1999] includes a patient with
moderate mental retardation and autistic features and a complex
rearrangement involving a large portion of chromosome 2q
(46,XY,t(1;2;13)(p21.2;q24.2-q36.2;q14.3)de novo). In both the
above cases, however, no further details regarding the breakpoints
could be determined.
There has been much recent debate regarding the relationship
betweenthecharacteristictriadofdeﬁcitsseeninautism(reciprocal
social interaction, communication, and repetitive and stereotyped
behaviors and interests) and the overlaps between these impair-
ments and those seen in other developmental disorders such as
SpeciﬁcLanguageImpairment(SLI)andmentalretardation(MR).
Although the majority of autistic individuals display deﬁcits in all
three of the triad areas, there remain individuals who fail to meet
criteria for one or more of the triad deﬁnitions. Furthermore, even
FIG. 3. Deletion mapping by FISH on metaphase chromosomes:
critical clones. For each image, the position of the hybridization
sitesoftherelevantclonesismarkedbyanarrow.ImagesA–Dare
fromPatient 1.Images E andFare fromPatient 2.Images A andB
showtheproximalboundariesofthedeletioninPatient1.ImagesC
and D show the distal boundaries of the deletion in Patient 1.
Images E and F show partially deleted clones spanning the
deletion boundaries in Patient 2. A: RP11-352J13 hybridizes to
both copies of chromosome 2. B: RP11-173H9 is deleted on one
copyhybridizestobothcopiesofchromosome2.C:RP11-183M18
hybridizes to a single copy of chromosome 2. D: RP11-637C13
hybridises to both copies of chromosome 2. E: RP11-621K10
showsabrightsignalononecopyofchromosome2,andaweaker
signal on its homologue indicating that it is partially deleted on
one copy. Note that this clone also hybridizes to another
chromosome and this image therefore includes a chromosome 2
paint allowing the identiﬁcation of the signiﬁcant hybridizations.
F:RP11-292A10showsabrightsignalononecopyofchromosome
2, and a weaker signal on its homologue indicating that it is
partially deleted on one copy.
594 AMERICAN JOURNAL OF MEDICAL GENETICS PART Ain those individuals who do carry the full triad of deﬁcits, the exact
nature of the impairments varies considerably both between in-
dividuals and over time. Thus, in light of emerging evidence that
identiﬁed genetic variants play a role in a relatively rare number of
cases with characteristic deﬁcits, there is growing support for a
degree of genetic separation between deﬁcit areas and for the
existence of shared genetic risk variants between developmental
disorders [Bailey etal., 1998].Under such ahypothesis, the surface
presentation of the disorder is highly dependent upon additional
modiﬁer componentswhichmay be genetic and/orenvironmental
innature.Thusalthoughonlyoneofthepatientsinvestigatedinthis
article had a positive diagnosis of ASD, the degree of overlap
between their impairments and the presence of an overlapping
chromosome abnormality was sufﬁcient to suggest a shared etiol-
ogy.Furthermore,giventhepresenceofASDinoneofthecasesand
the continued links between the deleted region and ASDs in the
wider population, it may be argued that the genes affected by
the deletions reported here should also be regarded as possible
candidates in idiopathic cases of autistic disorder. Advances in
microarray technology mean that it would now be possible to
perform genome-wide screens for ancillary, sub-microscopic,
rearrangements (CNVs) or additional shared genetic features in
these patients. Such a step would enable the evaluation of the
described deletion in the context of the whole genome and may
therefore provide valuable information regarding the relationship
between shared genetic and surface features in these two
individuals.
Previousinvestigationshavedemonstratedthevalueofmultiple
clustered chromosome abnormalities in the search for genes un-
derlying linkage signals and itwould therefore be of interest toalso
screen the three genes surrounding the deletion in a larger autistic
cohort. Recent evidence suggests that the parallel use of comple-
mentary genetic approaches will ultimately enable the identiﬁca-
tion of genes which predispose individuals to the development of
autistic traits, and it is hoped that this will promote a better
understanding of the biological basis of these disorders.
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